You are currently on the new version of our website. Access the old version .

593 Results Found

  • Review
  • Open Access
64 Citations
8,185 Views
41 Pages

Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer’s, Parkinson’s, and Huntington’s Diseases and Amyotrophic Lateral Sclerosis

  • Alexandru Vlad Ciurea,
  • Aurel George Mohan,
  • Razvan-Adrian Covache-Busuioc,
  • Horia-Petre Costin,
  • Luca-Andrei Glavan,
  • Antonio-Daniel Corlatescu and
  • Vicentiu Mircea Saceleanu

Neurodegenerative diseases are, according to recent studies, one of the main causes of disability and death worldwide. Interest in molecular genetics has started to experience exponential growth thanks to numerous advancements in technology, shifts i...

  • Review
  • Open Access
28 Citations
6,162 Views
21 Pages

Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington’s Disease and Other Neurodegenerative Disorders

  • Pasquale Sileo,
  • Clémence Simonin,
  • Patricia Melnyk,
  • Marie-Christine Chartier-Harlin and
  • Philippe Cotelle

16 November 2022

The Hippo pathway consists of a cascade of kinases that controls the phosphorylation of the co-activators YAP/TAZ. When unphosphorylated, YAP and TAZ translocate into the nucleus, where they mainly bind to the TEAD transcription factor family and act...

  • Review
  • Open Access
4 Citations
5,893 Views
46 Pages

Multitarget Compounds Designed for Alzheimer, Parkinson, and Huntington Neurodegeneration Diseases

  • Eleftheria-Emmanouela Katsoulaki,
  • Dimitrios Dimopoulos and
  • Dimitra Hadjipavlou-Litina

Multitarget drugs are molecules with the ability to act simultaneously on different targets at the same time, and they have been evaluated in the last decade as a powerful tool in the development of promising therapeutics for neurodegenerative diseas...

  • Review
  • Open Access
22 Citations
8,368 Views
50 Pages

Diabetes mellitus (DM) and neurodegenerative diseases/disturbances are worldwide health problems. The most common chronic conditions diagnosed in persons 60 years and older are type 2 diabetes mellitus (T2DM) and cognitive impairment. It was found th...

  • Editorial
  • Open Access
4 Citations
3,677 Views
3 Pages

11 September 2020

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD), severely impact the function of neuronal cells in the brain and have devastating consequences on the quality of lif...

  • Feature Paper
  • Review
  • Open Access
48 Citations
7,654 Views
16 Pages

Mitophagy Regulates Neurodegenerative Diseases

  • Xufeng Cen,
  • Manke Zhang,
  • Mengxin Zhou,
  • Lingzhi Ye and
  • Hongguang Xia

24 July 2021

Mitochondria play an essential role in supplying energy for the health and survival of neurons. Mitophagy is a metabolic process that removes dysfunctional or redundant mitochondria. This process preserves mitochondrial health. However, defective mit...

  • Case Report
  • Open Access
467 Views
12 Pages

Early Psychotic Symptoms as Indicators of Huntington’s Disease Onset

  • Bianca Daniela Crecan-Suciu,
  • Patricea Iulia Huluba,
  • Adela Melania Hanga,
  • Olivia Verișezan Roșu and
  • Ramona Liana Păunescu

Introduction: Huntington’s disease is a genetic disorder, also known as an autosomal dominant neurodegenerative disease, that has typical manifestations such as motor disturbances, cognitive decline, and psychiatric symptoms. Neurologists initi...

  • Review
  • Open Access
32 Citations
4,850 Views
19 Pages

Role of Sirtuin 3 in Degenerative Diseases of the Central Nervous System

  • Haofuzi Zhang,
  • Shuhui Dai,
  • Yuefan Yang,
  • Jialiang Wei,
  • Xin Li,
  • Peng Luo and
  • Xiaofan Jiang

24 April 2023

An NAD+-dependent deacetylase called Sirtuin 3 (Sirt3) is involved in the metabolic processes of the mitochondria, including energy generation, the tricarboxylic acid cycle, and oxidative stress. Sirt3 activation can slow down or prevent mitochondria...

  • Review
  • Open Access
15 Citations
7,599 Views
24 Pages

20 July 2020

Prion diseases are fatal, transmissible neurodegenerative disorders whose pathogenesis is driven by the misfolding, self-templating and cell-to-cell spread of the prion protein. Other neurodegenerative diseases such as Alzheimer’s disease, Park...

  • Review
  • Open Access
117 Citations
13,094 Views
26 Pages

7 August 2020

Neurodegenerative diseases are the second most common cause of death and characterized by progressive impairments in movement or mental functioning in the central or peripheral nervous system. The prevention of neurodegenerative disorders has become...

  • Review
  • Open Access
59 Citations
14,376 Views
23 Pages

Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways

  • Amanda Cano,
  • Elena Fonseca,
  • Miren Ettcheto,
  • Elena Sánchez-López,
  • Itziar de Rojas,
  • Silvia Alonso-Lana,
  • Xavier Morató,
  • Eliana B. Souto,
  • Manuel Toledo and
  • Agustín Ruíz
  • + 2 authors

18 October 2021

Epilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not...

  • Review
  • Open Access
5 Citations
3,507 Views
20 Pages

Cyclitols: From Basic Understanding to Their Association with Neurodegeneration

  • Maria Derkaczew,
  • Piotr Martyniuk,
  • Adam Osowski and
  • Joanna Wojtkiewicz

23 April 2023

One of the most common cyclitols found in eukaryotic cells—Myo-inositol (MI) and its derivatives play a key role in many cellular processes such as ion channel physiology, signal transduction, phosphate storage, cell wall formation, membrane bi...

  • Review
  • Open Access
289 Citations
27,833 Views
21 Pages

Old Drugs as New Treatments for Neurodegenerative Diseases

  • Fernando Durães,
  • Madalena Pinto and
  • Emília Sousa

Neurodegenerative diseases are increasing in number, given that the general global population is becoming older. They manifest themselves through mechanisms that are not fully understood, in many cases, and impair memory, cognition and movement. Curr...

  • Review
  • Open Access
1 Citations
4,931 Views
35 Pages

Glucose is the main source of energy and the source of carbon for the biosynthesis of several molecules, such as neurotransmitters, for most mammalian cells. Therefore, the transport of glucose into cells is very important. There are described three...

  • Review
  • Open Access
14 Citations
4,726 Views
21 Pages

Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders

  • Tapan Behl,
  • Rashita Makkar,
  • Aayush Sehgal,
  • Neelam Sharma,
  • Sukhbir Singh,
  • Mohammed Albratty,
  • Asim Najmi,
  • Abdulkarim M. Meraya and
  • Simona Gabriela Bungau

4 August 2022

The longstanding progressive neurodegenerative conditions of the central nervous system arise mainly due to deterioration, degradation and eventual neuronal cell loss. As an individual ages, the irreversible neurodegenerative disorders associated wit...

  • Review
  • Open Access
35 Citations
4,299 Views
18 Pages

8 August 2023

This review explores the emerging role of hydrogen sulfide (H2S) in modulating epigenetic mechanisms involved in neurodegenerative diseases. Accumulating evidence has begun to elucidate the multifaceted ways in which H2S influences the epigenetic lan...

  • Review
  • Open Access
11 Citations
4,568 Views
43 Pages

Perinatal Tissue-Derived Stem Cells: An Emerging Therapeutic Strategy for Challenging Neurodegenerative Diseases

  • Annalisa Bruno,
  • Cristina Milillo,
  • Federico Anaclerio,
  • Carlotta Buccolini,
  • Anastasia Dell’Elice,
  • Ilaria Angilletta,
  • Marco Gatta,
  • Patrizia Ballerini and
  • Ivana Antonucci

Over the past 20 years, stem cell therapy has been considered a promising option for treating numerous disorders, in particular, neurodegenerative disorders. Stem cells exert neuroprotective and neurodegenerative benefits through different mechanisms...

  • Review
  • Open Access
21 Citations
7,603 Views
23 Pages

Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases

  • Hueng-Chuen Fan,
  • Ching-Shiang Chi,
  • Shin-Nan Cheng,
  • Hsiu-Fen Lee,
  • Jeng-Dau Tsai,
  • Shinn-Zong Lin and
  • Horng-Jyh Harn

Neurodegenerative diseases (NDs) are among the most feared of the disorders that afflict humankind for the lack of specific diagnostic tests and effective treatments. Understanding the molecular, cellular, biochemical changes of NDs may hold therapeu...

  • Review
  • Open Access
19 Citations
6,076 Views
20 Pages

Mushroom Natural Products in Neurodegenerative Disease Drug Discovery

  • Arjuna Abitbol,
  • Brody Mallard,
  • Evelin Tiralongo and
  • Joe Tiralongo

6 December 2022

The variety of drugs available to treat neurodegenerative diseases is limited. Most of these drug’s efficacy is restricted by individual genetics and disease stages and usually do not prevent neurodegeneration acting long after irreversible dam...

  • Review
  • Open Access
11 Citations
5,403 Views
17 Pages

31 October 2024

Ion channels are integral membrane proteins embedded in biological membranes, and they comprise specific proteins that control the flow of ion transporters in and out of cells, playing crucial roles in the biological functions of different cells. The...

  • Review
  • Open Access
225 Citations
18,030 Views
19 Pages

Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases

  • Ju Gao,
  • Luwen Wang,
  • Jingyi Liu,
  • Fei Xie,
  • Bo Su and
  • Xinglong Wang

Neurodegenerative diseases are incurable and devastating neurological disorders characterized by the progressive loss of the structure and function of neurons in the central nervous system or peripheral nervous system. Mitochondria, organelles found...

  • Review
  • Open Access
50 Citations
13,564 Views
61 Pages

Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review

  • Aswir Abd Rashed,
  • Ahmad Zuhairi Abd Rahman and
  • Devi Nair Gunasegavan Rathi

19 February 2021

Despite the improvements in life expectancy, neurodegenerative conditions have arguably become the most dreaded maladies of older people. The neuroprotective and anti-ageing potentials of essential oils (EOs) are widely evaluated around the globe. Th...

  • Feature Paper
  • Review
  • Open Access
33 Citations
8,923 Views
35 Pages

Biochemical Pathways of Cellular Mechanosensing/Mechanotransduction and Their Role in Neurodegenerative Diseases Pathogenesis

  • Ilaria Tortorella,
  • Chiara Argentati,
  • Carla Emiliani,
  • Francesco Morena and
  • Sabata Martino

1 October 2022

In this review, we shed light on recent advances regarding the characterization of biochemical pathways of cellular mechanosensing and mechanotransduction with particular attention to their role in neurodegenerative disease pathogenesis. While the me...

  • Review
  • Open Access
63 Citations
10,210 Views
32 Pages

MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases

  • T. P. Nhung Nguyen,
  • Mandeep Kumar,
  • Ernesto Fedele,
  • Giambattista Bonanno and
  • Tiziana Bonifacino

MicroRNAs (miRNAs) are essential post-transcriptional gene regulators involved in various neuronal and non-neuronal cell functions and play a key role in pathological conditions. Numerous studies have demonstrated that miRNAs are dysregulated in majo...

  • Review
  • Open Access
360 Citations
22,265 Views
27 Pages

Ferroptosis Mechanisms Involved in Neurodegenerative Diseases

  • Cadiele Oliana Reichert,
  • Fábio Alessandro de Freitas,
  • Juliana Sampaio-Silva,
  • Leonardo Rokita-Rosa,
  • Priscila de Lima Barros,
  • Debora Levy and
  • Sérgio Paulo Bydlowski

20 November 2020

Ferroptosis is a type of cell death that was described less than a decade ago. It is caused by the excess of free intracellular iron that leads to lipid (hydro) peroxidation. Iron is essential as a redox metal in several physiological functions. The...

  • Review
  • Open Access
44 Citations
8,281 Views
33 Pages

Neurodegenerative diseases are inseparably linked with aging and increase as life expectancy extends. There are common dysfunctions in various cellular events shared among neurogenerative diseases, such as calcium dyshomeostasis, neuroinflammation, a...

  • Review
  • Open Access
47 Citations
7,866 Views
26 Pages

Pathogenesis of Huntington’s Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies

  • Zainab Irfan,
  • Sofia Khanam,
  • Varnita Karmakar,
  • Sayeed Mohammed Firdous,
  • Bothaina Samih Ismail Abou El Khier,
  • Ilyas Khan,
  • Muneeb U. Rehman and
  • Andleeb Khan

14 October 2022

Background: Huntington’s disease is an inherited autosomal dominant trait neuro-degenerative disorder caused by changes (mutations) of a gene called huntingtin (htt) that is located on the short arm (p) of chromosome 4, CAG expansion mutation....

  • Review
  • Open Access
22 Citations
4,522 Views
17 Pages

Nrf2 Pathway in Huntington’s Disease (HD): What Is Its Role?

  • Paolo Tucci,
  • Roberta Lattanzi,
  • Cinzia Severini and
  • Luciano Saso

3 December 2022

Huntington’s disease (HD) is an autosomal dominant neurodegenerative disease that occurs worldwide. Despite some progress in understanding the onset of HD, drugs that block or delay symptoms are still not available. In recent years, many treatm...

  • Systematic Review
  • Open Access
11 Citations
5,353 Views
21 Pages

A 20-Year Systematic Review of the ‘Reading the Mind in the Eyes’ Test across Neurodegenerative Conditions

  • Owen Stafford,
  • Christina Gleeson,
  • Ciara Egan,
  • Conall Tunney,
  • Brendan Rooney,
  • Fiadhnait O’Keeffe,
  • Garret McDermott,
  • Simon Baron-Cohen and
  • Tom Burke

31 August 2023

Social cognition has a broad theoretical definition, which includes the ability to mentalise, i.e., recognise and infer mental states to explain and predict another’s behaviour. There is growing recognition of the clinical, diagnostic, and prog...

  • Review
  • Open Access
9 Citations
4,056 Views
23 Pages

17 February 2024

Neurodegenerative diseases encompass a heterogeneous group of disorders that afflict millions of people worldwide. Characteristic protein aggregates are histopathological hallmark features of these disorders, including Amyloid β (Aβ)-contai...

  • Review
  • Open Access
1 Citations
3,093 Views
22 Pages

Neurodegenerative diseases (NDDs), including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), and prion disease, represent a group of age-related disorders that pose...

  • Review
  • Open Access
17 Citations
4,904 Views
13 Pages

The Role of miR-128 in Neurodegenerative Diseases

  • Marika Lanza,
  • Salvatore Cuzzocrea,
  • Salvatore Oddo,
  • Emanuela Esposito and
  • Giovanna Casili

Several neurodegenerative disorders are characterized by the accumulation of misfolded proteins and are collectively known as proteinopathies. Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD) represe...

  • Review
  • Open Access
304 Views
46 Pages

7 January 2026

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD) are characterized by complex pathologies with progressive neurodegeneration, protein misfolding, oxidative stress,...

  • Review
  • Open Access
75 Citations
11,845 Views
27 Pages

23 January 2014

The transplantation of mesenchymal stem cells (MSCs) for treating neurodegenerative disorders has received growing attention recently because these cells are readily available, easily expanded in culture, and when transplanted, survive for relatively...

  • Review
  • Open Access
57 Citations
11,660 Views
34 Pages

Physical Exercise-Induced Myokines in Neurodegenerative Diseases

  • Banseok Lee,
  • Myeongcheol Shin,
  • Youngjae Park,
  • So-Yoon Won and
  • Kyoung Sang Cho

Neurodegenerative diseases (NDs), such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), are disorders characterized by progressive degeneration of the nervous system. Currently...

  • Review
  • Open Access
67 Citations
15,777 Views
29 Pages

Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications

  • Paras Mani Giri,
  • Anurag Banerjee,
  • Arpita Ghosal and
  • Buddhadev Layek

Neurodegenerative disorders (NDs) have become increasingly common during the past three decades. Approximately 15% of the total population of the world is affected by some form of NDs, resulting in physical and cognitive disability. The most common N...

  • Review
  • Open Access
52 Citations
14,140 Views
15 Pages

The main objectives of this review are to survey the current literature on the role of epigenetics in determining the fate of stem cells and to assess how this information can be used to enhance the treatment strategies for some neurodegenerative dis...

  • Feature Paper
  • Review
  • Open Access
36 Citations
6,297 Views
46 Pages

All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration

  • Shirel Argueti-Ostrovsky,
  • Leenor Alfahel,
  • Joy Kahn and
  • Adrian Israelson

16 September 2021

Multiple neurodegenerative diseases (NDDs) such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and Huntington’s disease (HD) are being suggested to have common cellular and molecular pathological mechanisms...

  • Review
  • Open Access
2,164 Views
29 Pages

14 August 2025

Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder characterized by progressive motor dysfunction, psychiatric disturbances, and cognitive decline. The pathophysiology of HD centers on a polyglutamine expansion in the...

  • Article
  • Open Access
8 Citations
3,213 Views
17 Pages

Gene Expression Profiling in Huntington’s Disease: Does Comorbidity with Depressive Symptoms Matter?

  • Gabriela Delevati Colpo,
  • Natalia Pessoa Rocha,
  • Erin Furr Stimming and
  • Antonio Lucio Teixeira

11 November 2020

Huntington’s disease (HD) is an inherited neurodegenerative disease. Besides the well-characterized motor symptoms, HD is marked by cognitive impairment and behavioral changes. In this study, we analyzed the blood of HD gene carries using RNA-s...

  • Review
  • Open Access
151 Citations
14,729 Views
23 Pages

An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases

  • Emilia Zgorzynska,
  • Barbara Dziedzic and
  • Anna Walczewska

4 September 2021

Nrf2 is a basic region leucine-zipper transcription factor that plays a pivotal role in the coordinated gene expression of antioxidant and detoxifying enzymes, promoting cell survival in adverse environmental or defective metabolic conditions. After...

  • Review
  • Open Access
5 Citations
3,345 Views
30 Pages

Intrathecal Therapies for Neurodegenerative Diseases: A Review of Current Approaches and the Urgent Need for Advanced Delivery Systems

  • Thomas Gabriel Schreiner,
  • Manuel Menéndez-González,
  • Oliver Daniel Schreiner and
  • Romeo Cristian Ciobanu

Neurodegenerative diseases (NDDs) pose an immense global health burden, and developing effective treatments is hindered by the blood–brain barrier (BBB). Intrathecal (IT) administration of therapeutics directly into the cerebrospinal fluid (CSF...

  • Review
  • Open Access
143 Citations
15,253 Views
30 Pages

Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases

  • Fang Luo,
  • Aaron F. Sandhu,
  • Wiramon Rungratanawanich,
  • George E. Williams,
  • Mohammed Akbar,
  • Shuanhu Zhou,
  • Byoung-Joon Song and
  • Xin Wang

28 September 2020

With aging, the nervous system gradually undergoes degeneration. Increased oxidative stress, endoplasmic reticulum stress, mitochondrial dysfunction, and cell death are considered to be common pathophysiological mechanisms of various neurodegenerativ...

  • Review
  • Open Access
24 Citations
6,771 Views
20 Pages

22 June 2020

Huntington’s disease is a severe and currently incurable neurodegenerative disease. An autosomal dominant mutation in the Huntingtin gene (HTT) causes an increase in the polyglutamine fragment length at the protein N-terminus. The consequence o...

  • Commentary
  • Open Access
30 Citations
7,121 Views
10 Pages

26 November 2018

Neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Huntington’s disease (HD), are characterized by intracellular aggregation of proteins. In the case of ALS and FTD, these protein aggrega...

  • Review
  • Open Access
7,708 Views
24 Pages

28 September 2025

Huntington’s Disease (HD) is an inherited neurodegenerative condition caused by an expansion of CAG repeats in the Huntingtin (HTT) gene, leading to a toxic form of the HTT protein. Despite advances in understanding the disease and developing s...

  • Review
  • Open Access
98 Citations
14,341 Views
30 Pages

The Role of Vitamins in Neurodegenerative Disease: An Update

  • Sachchida Nand Rai,
  • Payal Singh,
  • Harry W.M. Steinbusch,
  • Emanuel Vamanu,
  • Ghulam Ashraf and
  • Mohan Prasad Singh

22 September 2021

Acquiring the recommended daily allowance of vitamins is crucial for maintaining homeostatic balance in humans and other animals. A deficiency in or dysregulation of vitamins adversely affects the neuronal metabolism, which may lead to neurodegenerat...

  • Review
  • Open Access
6 Citations
3,414 Views
18 Pages

Circadian Interventions in Preclinical Models of Huntington’s Disease: A Narrative Review

  • Derek Dell’Angelica,
  • Karan Singh,
  • Christopher S. Colwell and
  • Cristina A. Ghiani

Huntington’s Disease (HD) is a neurodegenerative disorder caused by an autosomal-dominant mutation in the huntingtin gene, which manifests with a triad of motor, cognitive and psychiatric declines. Individuals with HD often present with disturb...

  • Article
  • Open Access
4 Citations
2,451 Views
11 Pages

Leukocyte Telomere Length as Potential Biomarker of HD Progression: A Follow-Up Study

  • Daniela Scarabino,
  • Liana Veneziano,
  • Elide Mantuano,
  • Ivan Arisi,
  • Alessia Fiore,
  • Marina Frontali and
  • Rosa Maria Corbo

3 November 2022

The identification of biomarkers for neurodegenerative disorders such as Huntington’s disease (HD) is crucial for monitoring disease progression and therapeutic trial outcomes, especially in the pre-manifest disease stage (pre-HD). In a previou...

  • Article
  • Open Access
6 Citations
2,750 Views
18 Pages

Huntington’s disease (HD) is a neurodegenerative disease that causes progressive motor and cognitive dysfunction. There is no cure for HD, and current therapeutics can only manage the signs and symptoms as well as slowing disease progression. T...

of 12